1 completed, 1 not yet recruiting, 1 recruiting, 1 unknown. 1 Not applicable, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Withdrawn 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Clopidogrel Resistance: new trials by email Literature Review of Clopidogrel Resistance trials Research Report on Clopidogrel Resistance
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Precision Antiplatelet Therapy Guided by Platelet Aggregation Function in Patients With Acute Ischemic STROKE The ticagrelor, The Clopidogrel - Acute Ischemic Stroke, Clopidogrel Resistance | Phase 3 | Recruiting | Sichuan Provincial People's Hospital | 5138 | 2025-05-23 | 2026-05-12 |
| Evaluation of the Efficacy of Novel Biomarkers in Predicting Clopidogrel Resistance in Patients with Ischemic Stroke Ischemic Stroke, TIA (Transient Ischemic Attack) | Not yet recruiting | Nanjing First Hospital, Nanjing Medical University | 800 | 2025-02-01 | 2024-12-31 | |
| The Study of CYP2C19 Genotype-Guided Clopidogrel Treatment Models CYP2C19 Genotype-Guided Clopidogrel Treatment, CYP2C19 Genotype Guided Antiplatelet Treatment Alternative to Clopidogrel, The Conventional Clopidogrel Treatment - Coronary Artery Disease, Clopidogrel Resistance | Not applicable | Completed | Vistamedi Ltd. | 283 | 2023-06-15 | 2025-09-26 |
| Platelet Reactivity, B-amyloid, MOTS-c and Mortality of Type II Diabetics With CAD Diabetes, Clopidogrel Resistance | Unknown | University of Athens | 120 | 2014-01-01 | 2019-07-23 | |
| Effect of Primidone on Platelet Responsiveness in Patients Determined to be Clopidogrel Resistant Primidone - Clopidogrel Resistance, Secondary Stroke Prevention | Phase 2 | Withdrawn | Dent Neuroscience Research Center | 2013-08-01 | 2016-08-03 |
Ischemic Stroke (2) · Alzheimer Disease (1) · Cardiovascular Diseases (1) · Coronary Artery Disease (1) · Coronary Thrombosis (1) · Death (1) · Diabetes Mellitus (1) · Hemorrhage (1) · Insulin Resistance (1) · Ischemic Attack, Transient (1)
Brain Diseases (3) · Central Nervous System Diseases (3) · Nervous System Diseases (3) · Vascular Diseases (3) · Cardiovascular Diseases (2) · Cerebrovascular Disorders (2) · Stroke (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Brain Ischemia (1) · Coronary Disease (1) · Dementia (1) · Embolism and Thrombosis (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1)
Primidone (1)
Dent Neuroscience Research Center (1) · Nanjing First Hospital, Nanjing Medical University (1) · Sichuan Provincial People's Hospital (1) · University of Athens (1) · Vistamedi Ltd. (1)
China (1) · Georgia (1) · Greece (1) · United States (1)
Ignatios Ikonomidis, AssProfessor (1) · Konstantine Liluashvili, MD., PH.D. (1) · Levan Jijeishvili, MD, MPH (1) · Tornike Batavani, MD, MPH (1) · Vernice Bates, M.D. (1)